A study to evaluate the amount of drug that becomes available to the blood circulation when inhaled by a nebulizer and dry powder inhaler in healthy subjects.

Trial Identifier: D3742C00001
Sponsor: AstraZeneca
Collaborator:
Parexel
NCTID:: NCT04072562
Start Date: September 2019
Primary Completion Date: November 2019
Study Completion Date: November 2019
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
German Translation

Trial Locations

Country Location
Germany Berlin, Germany, 14050